Skip to main content

Digestive System Disease and Sudden Death

  • Chapter
  • First Online:
Sudden Death

Abstract

Although sudden death caused by digestive system diseases, accounting for about 7% of sudden death diseases, is not common compared with other diseases such as cardiovascular disease, it is also worthy of attention. Among them, sudden death caused by acute pancreatitis is the most common, accounting for 0.2%-0.5% of natural sudden death, and is one of the important causes of non-cardiac sudden death. This chapter mainly focuses on a series of sudden death related digestive system diseases, including ischemic bowel disease, variceal upper gastrointestinal bleeding in cirrhotic portal hypertension, hepatic encephalopathy, liver failure, acute suppurative cholangitis and acute pancreatitis. This type of disease is characterized by a rapid onset, a rapid progress, and a high mortality rate. Combining typical cases, this chapter describes the pathogenesis, diagnosis and treatment progress of the above-mentioned diseases that may cause sudden death.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Brandt LJ, Boley SJ. AGA technical review on intestinal ischemia. Gastroenterology. 2000;118(5):954–68.

    Article  CAS  PubMed  Google Scholar 

  2. Jaster A, Choudhery S, Ahn R, Sutphin P, Kalva S, Anderson M, et al. Anatomic and radiologic review of chronic mesenteric ischemia and its treatment. Clin Imaging. 2016;40(5):961–9.

    Article  PubMed  Google Scholar 

  3. Corcos O, Nuzzo A. Gastro-intestinal vascular emergencies. Best Pract Res Clin Gastroenterol. 2013;27(5):709–25.

    Article  PubMed  Google Scholar 

  4. Brandt LJ, Feuerstadt P, Longstreth GF, Boley SJ. ACG clinical guideline: epidemiology, risk factors, patterns of presentation, diagnosis, and management of colon ischemia (CI). Am J Gastroenterol. 2015;110(1):18–44.

    Article  PubMed  Google Scholar 

  5. Flynn AD, Valentine JF. Update on the diagnosis and management of colon ischemia. Curr Treat Option Gastroenterol. 2016;14(1):128–39.

    Article  Google Scholar 

  6. Yadav S, Dave M, Edakkanambeth VJ, Harmsen WS, Tremaine WJ, Zinsmeister AR, et al. A population-based study of incidence, risk factors, clinical spectrum, and outcomes of ischemic colitis. Clin Gastroenterol Hepatol. 2015;13(4):731–8.

    Article  PubMed  Google Scholar 

  7. Brandt L, Boley S, Goldberg L, Mitsudo S, Berman A, et al. Colitis in the elderly. A reappraisal. Am J Gastroenterol. 1981;76(3):239–45.

    CAS  PubMed  Google Scholar 

  8. Kozuch PL, Brant LJ. Review article: diagnosis and management of mesenteric ischemia with an emphasis on pharmacotherapy. Aliment Pharmacol Ther. 2005;21(3):201–15.

    Article  CAS  PubMed  Google Scholar 

  9. Van der Voort PH, Westra B, Wester JP, Bosman RJ, van Stijn I, Haagen IA, et al. Can serum L-lactate, D-lactate, creatine kinase and I-FABP be used as diagnostic markers incritically ill patients suspected for bowel ischemia. BMC Anesthesiol. 2014;14:111.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Assadian A, Assadian O, Senekowitsch C, Rotter R, Bahrami S, Furst W, et al. Plasma D-lactate as a potential early marker for colon ischaemia after open aortic reconstruction. Eur J Vasc Endovasc Surg. 2006;31(5):470–4.

    Article  CAS  PubMed  Google Scholar 

  11. Levy E, Menard D, Delvin E, Montoudis A, Beaulieu JF, Mailhot G, et al. Localization, function and regulation of the two intestinal fatty acid-binding protein types. Histochem Cell Biol. 2009;132(3):35l–67.

    Article  CAS  Google Scholar 

  12. Kanda T, Hujii H, Tani T, Murakami H, Suda T, Sakai Y, et al. Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology. 1996;110(2):339–43.

    Article  CAS  PubMed  Google Scholar 

  13. Akyildiz H, Akcan A, Oztürk A, Sozuer E, Kucuk C, Karahan I. The correlation of the D-dimer test and biphasic computed tomography with mesenteric computed tomography angiography in the diagnosis of acute mesenteric ischemia. Am J Surg. 2009;197(4):429–33.

    Article  PubMed  Google Scholar 

  14. Sutherland F, Cunningham H, Pontikes L, Parsons L, Klassen J. Elevated serum interleukin-6 levels in patients with acute intestinal ischemia. Hepato-Gastroenterology. 2003;50(50):419–21.

    CAS  PubMed  Google Scholar 

  15. Acosta S, Nilsson TK, Bjorck M. Preliminary study of D-dimer as a possible marker of acute bowel ischaemia. Br J Surg. 2001;88(3):385–8.

    Article  CAS  PubMed  Google Scholar 

  16. Woodhams R, Nishimaki H, Fujii K, Kakita S, Hayakawa K. Usefulness of multidetector-row CT (MDCT) for the diagnosis of non-occlusive mesenteric ischemia (NOMI): assessment of morphology and diameter of the superior mesenteric artery (SMA) on multi-planar reconstructed (MPR) images. Eur J Radiol. 2010;76(1):96–102.

    Article  PubMed  Google Scholar 

  17. Resch T, Lindh M, Dias N, Sonesson B, Uher P, Malina M, et al. Endovascular recanalisation in occlusive mesenteric ischemia feasibility and early results. Eur J Vasc Endovasc Surg. 2005;29(2):199–203.

    Article  CAS  PubMed  Google Scholar 

  18. Acosta S, Wadman M, Syk I, Elmstahl S, Ekberg O. Epidemiology and prognostic factors in acute superior mesenteric artery occlusion. J Gastrointest Surg. 2010;14(4):628–35.

    Article  PubMed  Google Scholar 

  19. Cangemi JR, Picco MF. Intestinal ischemia in the elderly. Gastroenterol Clin N Am. 2009;38(3):527–40.

    Article  Google Scholar 

  20. Wadman M, Syk I, Elmståhl B, Ekberg O, Elmstahl S. Abdominal plain film findingsin acute ischemic bowel disease differ with age. Acta Radiol. 2006;47(3):238–43.

    Article  CAS  PubMed  Google Scholar 

  21. Laissy JP, Trillaud H, Douek P. MR angiography: noninvasive vascular imaging of the abdomen. Abdom Imaging. 2002;27(5):488–506.

    Article  CAS  PubMed  Google Scholar 

  22. Stathaki MI, Koutroubakis IE, Koukouraki SI, Kouroumalis EA, Karkavitsas NS. Is there a role for Tc-99m(V) DMSA scintigraphy in ischemic colitis? World J Gastroenterol. 2008;14(35):5432–5.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Polk JD, Rael LT, Craun ML, Mains CW, Davis-Merritt D, Bar-Or D. Clinical utility of the cobalt-albumin binding assay in the diagnosis of intestinal ischemia. J Trauma. 2008;64(1):42–5.

    CAS  PubMed  Google Scholar 

  24. Theodoropoulou A, Koutroubakis IE. Ischemic colitis: clinical practice in diagnosis and treatment. World J Gastroenterol. 2008;14(48):7302–8.

    Article  PubMed  Google Scholar 

  25. Clinical Services and Standards Committee of the British Society of Gastroenterology. U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut. 2015;64(11):1680–704.

    Article  Google Scholar 

  26. De Franchis R, Baveno VI Faculty. Expanding consensus in portal hypertension: report of the Baveno VI Consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743–52.

    Article  PubMed  Google Scholar 

  27. European Association for the Study of the Liver. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406–60.

    Article  Google Scholar 

  28. Acute upper gastrointestinal bleeding: management. 2012. NGC:009131 National Clinical Guideline Centre—National Government Agency [Non-U.S].

    Google Scholar 

  29. Esophageal varices. World Gastroenterology Organisation Global Guidelines. 2014.

    Google Scholar 

  30. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Lévy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004;40(3):652–9.

    Article  PubMed  Google Scholar 

  31. Tripathi D, Stanley AJ, Hayes PC, Patch D, Millson C, Mehrzad H, et al. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut. 2015;64(11):1680–704.

    Article  PubMed  Google Scholar 

  32. Kim YD. Management of acute variceal bleeding. Clin Endosc. 2014;47(4):308–14.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Vorobioff JD, Groszmann RJ. Prevention of portal hypertension:from variceal development to clinical decompensation. Hepatology. 2015;61(1):375–81.

    Article  PubMed  Google Scholar 

  34. Li M, Xu X. Researches on the prevention and treatment of bleeding gastroesophageal varices secondary to portal hypertension in patients with cirrhosis. Zhonghua Gan Zang Bing Za Zhi. 2015;23(4):247–9. (in Chinese)

    PubMed  Google Scholar 

  35. Kim DH, Park JY. Prevention and management of variceal hemorrhage. Int J Hepatol. 2013;2013:434609.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Lee YY, Tee HP, Mahadeva S. Role of prophylactic antibiotics in cirrhotic patients with variceal bleeding. World J Gastroenterol. 2014;20(7):1790–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Hwang JH, Shergill AK, Acosta RD, Chandrasekhara V, Chathadi KV, Decker GA, et al. The role of endoscopy in the management of variceal hemorrhage. Gastrointest Endosc. 2014;80(2):221–7.

    Article  PubMed  Google Scholar 

  38. Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Endoscopy, Chinese Medical Association. Guidelines for the diagnosis and treatment of esophageal and gastric variceal bleeding in cirrhotic portal hypertension. J Chin Hepatol. 2016;32(2):203–19. (in Chinese)

    Google Scholar 

  39. Hearnshaw S, Logan R, Lowe D, Travis S, Murphy M, Palmer K. Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut. 2007;60:1327–35.

    Article  Google Scholar 

  40. Garcia-Tsao G, Bosch J. Management of varices and variceal haemorrhage in cirrhosis. N Engl J Med. 2010;362:823–32.

    Article  CAS  PubMed  Google Scholar 

  41. Garbuzenko DV. Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis. World J Gastroenterol. 2015;21(20):6117–26.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Sarin SK, Kumar A. Endoscopic treatment of gastric varices. Clin Liver Dis. 2014;18(4):809–27.

    Article  PubMed  Google Scholar 

  43. Huang L, Yu QS, Zhang Q, Liu JD, Wang Z. Transjugular intrahepatic portosystemic shunt versus surgical shunting in the management of portal hypertension. Chin Med J. 2015;128(6):826–34.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Orloff MJ, Hye RJ, Wheeler HO, Isenberg JI, Haynes KS, Vaida F, et al. Randomized trials of endoscopic therapy and transjugular intrahepatic portosystemic shunt versus portacaval shunt for emergency and elective treatment of bleeding gastric varices in cirrhosis. Surgery. 2015;157(6):1028–45.

    Article  PubMed  Google Scholar 

  45. Chinese Medical Association Surgery Branch, Department of Portal Hypertension. Expert agreement on diagnosis and treatment of esophageal and gastric varices bleeding in cirrhotic portal hypertension. J Pract Surg. 2015;23(10):1086–90. (in Chinese)

    Google Scholar 

  46. Hadjihambi A, Arias N, Sheikh M, Jalan R. Hepatic encephalopathy: a critical current review. Hepatol Int. 2018;12(61):135–47.

    Article  PubMed  Google Scholar 

  47. Tranah TH, Paolino A, Shawcross DL. Pathophysiological mechanisms of hepatic encephalopathy. Clin Liver Dis. 2015;5(3):59–63.

    Article  CAS  Google Scholar 

  48. Elwir S, Rahimi RS. Hepatic encephalopathy: an update on the pathophysiology and therapeutic options. J Clin Transl Hepatol. 2017;5(2):142–51.

    PubMed  PubMed Central  Google Scholar 

  49. Ochoasanchez R, Rose CF. Pathogenesis of hepatic encephalopathy in chronic liver disease. J Clin Exp Hepatol. 2018;8(3):262–71.

    Article  Google Scholar 

  50. Kenston SS, Song X, Li Z, Zhao J. Mechanistic insight, diagnosis, and treatment of ammonia-induced hepatic encephalopathy. J Gastroenterol Hepatol. 2019;34(1):31–9.

    Article  Google Scholar 

  51. Jayakumar AR, Norenberg MD. Hyperammonemia in hepatic encephalopathy. J Clin Exp Hepatol. 2018;8(3):272–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Zwingmann C, Butterworth R. An update on the role of brain glutamine synthesis and its relation to cell-specific energy metabolism in the hyperammonemic brain: further studies using NMR spectroscopy. Neurochem Int. 2005;47:19–30.

    Article  CAS  PubMed  Google Scholar 

  53. Grover VP, Tognarelli JM, Massie N, Crossey MM, Cook NA, Taylorrobinson SD. The why and wherefore of hepatic encephalopathy. Int J General Med. 2015;8(1):381–90.

    CAS  Google Scholar 

  54. Felipo V. Hepatic encephalopathy: effects of liver failure on brain function. Nat Rev Neurosci. 2013;14(12):851–8.

    Article  CAS  PubMed  Google Scholar 

  55. Krieger D, Krieger S, Theilmann L, Jansen O, Gass P, Lichtnecker H. Manganese and chronic hepatic encephalopathy. Lancet. 1995;346(8970):270–4.

    Article  CAS  PubMed  Google Scholar 

  56. Chinese Society of Gastroenterology, Chinese Society of Hepatology, Chinese Medical Association. Consensus on the diagnosis and treatment of hepatic encephalopathy in China (Chongqing, 2013). Chin J Hepatol. 2013;21(9):641–51.

    Google Scholar 

  57. Amodio P. Hepatic encephalopathy: diagnosis and management. Liver Int. 2018;38(6):966–75.

    Article  PubMed  Google Scholar 

  58. Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopatlly—definition, nomenclature, diagnosis ,and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna. Hepatology. 2002;35(3):716–21.

    Article  PubMed  Google Scholar 

  59. Patidar KR, Bajaj JS. Covert and overt hepatic encephalopathy: diagnosis and management. Clin Gastroenterol Hepatol. 2015;13(12):2048–61.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Fischer JE, Rosen HM, Ebeid AM, James JH, Keane J, Soeters PB. The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery. 1976;80(1):77–91.

    CAS  PubMed  Google Scholar 

  61. Coronel-Castillo CE, Contreras-Carmona J, Frati-Munari AC, Uribe M, Méndez-Sánchez N. Efficacy of rifaximin in the different clinical scenarios of hepatic encephalopathy. Rev Gastroenterol Mex. 2020;85(1):56–68.

    CAS  Google Scholar 

  62. Tilg H, Cani PD, Mayer EA. Gut microbiome and liver diseases. Gut. 2016;65(12):2035–44.

    Article  CAS  PubMed  Google Scholar 

  63. Schwenger KJ, Clermont-Dejean N, Allard JP. The role of the gut microbiome in chronic liver disease: the clinical evidence revised. JHEP Rep. 2019;1(3):214–26.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Dam G, Aamann L, Vistrup H, Gluud LL. The role of branched chain amino acids in the treatment of hepatic encephalopathy. J Clin Exp Hepatol. 2018;8(4):448–51.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association et al. Guideline for diagnosis and treatment of liver failure. Chin J Hepatol. 2019;27(1):18–26.

    Google Scholar 

  66. Wendon J, Cordoba J, Dhawan A, Larsen FS, Manns M, Samuel D, et al. EASL clinical practical guidelines on the management of acute(fulminant)liver failure. J Hepatol. 2017;66(5):1047–81.

    Article  PubMed  Google Scholar 

  67. Flamm SL, Yang YX, Singh S, Falck-Ytter YT. American gastroenterological association institute guidelines for the diagnosis and management of acute liver failure. Gastroenterology. 2017;152(3):644–7.

    Article  PubMed  Google Scholar 

  68. Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13(4):353–90.

    Article  PubMed  Google Scholar 

  69. Shao J, Li S, Liu Y, Zheng M. Extracellular vesicles participate in macrophage-involved immune responses under liver diseases. Life Sci. 2020;240:117094.

    Article  PubMed  CAS  Google Scholar 

  70. Dong V, Nanchal R, Karvellas CJ. Pathophysiology of acute liver failure. Nutr Clin Pract. 2020;35(1):24–9.

    Article  PubMed  Google Scholar 

  71. Han T, Li LJ. Guideline for diagnosis and treatment of liver failure. J Clin Hepatol. 2018;35(1):38–44.

    Google Scholar 

  72. Tujios SR, Lee WM. Acute liver failure induced by idiosyncratic reaction to drugs: challenges in diagnosis and therapy. Liver Int. 2018;38(1):6–14.

    Article  PubMed  Google Scholar 

  73. Louvet A, Mathurin P. Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat Rev Gastroenterol Hepatol. 2015;12(4):231–42.

    Article  PubMed  Google Scholar 

  74. Im GY. Acute alcoholic hepatitis. Clin Liver Dis. 2019;23(1):81–98.

    Article  PubMed  Google Scholar 

  75. Ishibashi H, Komori A, Shimoda S, Gershwin ME. Guidelines for therapy of autoimmune liver disease. Semin Liver Dis. 2007;27(2):214–26.

    Article  CAS  PubMed  Google Scholar 

  76. Yi LP, Zhang W, Wu Z, Duan WJ, Wang Y, Huang J, et al. Present status of diagnosis and treatment of hepatolenticular degeneration. Zhonghua Gan Zang Bing Za Zhi. 2019;27(3):161–5.

    CAS  PubMed  Google Scholar 

  77. Emmanuel T, Audrey C, Silvio N, Josh L, Yaman T, Mark G, et al. International liver transplantation consensus statement on end-stage liver disease due to nonalcoholic steatohepatitis and liver transplantation. Transplantation. 2019;103(1):45–56.

    Article  Google Scholar 

  78. Andrew DJ, Johnson SE. Acute suppurative cholangitis, a medical and surgical emergency. A review of ten years experience emphasizing early recognition. Am J Gastroenterol. 1970;54:141–54.

    CAS  PubMed  Google Scholar 

  79. Shimada H, Nakagawara G, Kobayashi M, et al. Pathogenesis and clinical features of acute cholangitis accompanied by shock. Jpn J Surg. 1984;14:269–77.

    Article  CAS  PubMed  Google Scholar 

  80. Gigot JF, Leese T, Dereme T, et al. Acute cholangitis. Multivariate analysis of risk factors. Ann Surg. 1989;209:435–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Kimura Y, Takada T, Kawarada Y, et al. Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines. J Hepato-Biliary-Pancreat Surg. 2007;14:15–26.

    Article  Google Scholar 

  82. Attasaranya S, Fogel EL, Lehman GA. Choledocholithiasis, ascending cholangitis, and gallstone pancreatitis. Med Clin North Am. 2008;92:925–60.

    Article  PubMed  Google Scholar 

  83. van den Hazel SJ, Speelman P, Tytgat GN, et al. Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis. Clin Infect Dis. 1994;19:279–86.

    Article  PubMed  Google Scholar 

  84. Tanaka A, Takada T, Kawarada Y, et al. Antimicrobial therapy for acute cholangitis: Tokyo Guidelines. J Hepato-Biliary-Pancreat Surg. 2007;14:59–67.

    Article  Google Scholar 

  85. Navaneethan U, Jayanthi V, Mohan P. Pathogenesis of cholangitis in obstructive jaundice-revisited. Minerva Gastroenterol Dietol. 2011;57:97–104.

    CAS  PubMed  Google Scholar 

  86. Schwed AC, Boggs MM, Pham XD, et al. Association of admission laboratory values and the timing of endoscopic retrograde cholangiopancreatography with clinical outcomes in acute cholangitis. JAMA Surg. 2016;151:1039–45.

    Article  PubMed  Google Scholar 

  87. Lee BS, Hwang JH, Lee SH, et al. Risk factors of organ failure in patients with bacteremic cholangitis. Dig Dis Sci. 2013;58:1091–9.

    Article  PubMed  Google Scholar 

  88. Yokoe M, Hata J, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25:41–54.

    Article  PubMed  Google Scholar 

  89. Sulzer JK, Ocuin LM. Cholangitis: causes, diagnosis, and management. Surg Clin North Am. 2019;99:175–84.

    Article  PubMed  Google Scholar 

  90. Umefune G, Kogure H, Hamada T, et al. Procalcitonin is a useful biomarker to predict severe acute cholangitis: a single-center prospective study. J Gastroenterol. 2017;52:734–45.

    Article  CAS  PubMed  Google Scholar 

  91. Shinya S, Sasaki T, Yamashita Y, et al. Procalcitonin as a useful biomarker for determining the need to perform emergency biliary drainage in cases of acute cholangitis. J Hepatobiliary Pancreat Sci. 2014;21:777–85.

    Article  PubMed  Google Scholar 

  92. Watanapa P. Recovery patterns of liver function after complete and partial surgical biliary decompression. Am J Surg. 1996;171:230–4.

    Article  CAS  PubMed  Google Scholar 

  93. Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:133–64.

    Article  PubMed  CAS  Google Scholar 

  94. Gomi H, Solomkin JS, Schlossberg D, et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25:3–16.

    Article  PubMed  Google Scholar 

  95. Abboud PA, Malet PF, Berlin JA, et al. Predictors of common bile duct stones prior to cholecystectomy: a meta-analysis. Gastrointest Endosc. 1996;44:450–5.

    Article  CAS  PubMed  Google Scholar 

  96. Buyukasik K, Toros AB, Bektas H, et al. Diagnostic and therapeutic value of ERCP in acute cholangitis. ISRN Gastroenterol. 2013;2013:191729.

    Article  PubMed  PubMed Central  Google Scholar 

  97. Sun Z, Zhu Y, Zhu B, et al. Controversy and progress for treatment of acute cholangitis after Tokyo Guidelines (TG13). Biosci Trends. 2016;10:22–6.

    Article  PubMed  Google Scholar 

  98. Ramchandani M, Pal P, Reddy DN. Endoscopic management of acute cholangitis as a result of common bile duct stones . Dig Endosc. 2017;29 Suppl 2:78–87.

    Google Scholar 

  99. Boulay BR, Lo SK. Endoscopic ultrasound-guided biliary drainage. Gastrointest Endosc Clin N Am. 2018;28:171–85.

    Article  PubMed  Google Scholar 

  100. Miura F, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci. 2018;25:31–40.

    Article  PubMed  Google Scholar 

  101. Liu C-T, Li P, Zhang S-T. ENBD. In: Mine T, Fujita R, editors. Advanced therapeutic endoscopy for pancreatico-biliary diseases. Tokyo: Springer Japan; 2019. p. 51–62.

    Chapter  Google Scholar 

  102. Sharaiha RZ, Khan MA, Kamal F, et al. Efficacy and safety of EUS-guided biliary drainage in comparison with percutaneous biliary drainage when ERCP fails: a systematic review and meta-analysis. Gastrointest Endosc. 2017;85:904–14.

    Article  PubMed  Google Scholar 

  103. Nennstiel S, Weber A, Frick G, et al. Drainage-related complications in percutaneous transhepatic biliary drainage: an analysis over 10 years. J Clin Gastroenterol. 2015;49:764–70.

    Article  PubMed  Google Scholar 

  104. Lai EC, Mok FP, Tan ES, et al. Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med. 1992;326:1582–6.

    Article  CAS  PubMed  Google Scholar 

  105. Portelli M, Jones CD. Severe acute pancreatitis: pathogenesis, diagnosis and surgical management. Hepatobiliary Pancreat Dis Int. 2017;16:155–9.

    Article  PubMed  Google Scholar 

  106. Roberts SE, Akbari A, Thorne K, Atkinson M, Evans PA. The incidence of acute pancreatitis: impact of social deprivation, alcohol consumption, seasonal and demographic factors. Aliment Pharmacol Ther. 2013;38:539–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Vege SS, Gardner TB, Chari ST, Munukuti P, Pearson RK, Clain JE, Petersen BT, Baron TH, Farnell MB, Sarr MG. Low mortality and high morbidity in severe acute pancreatitis without organ failure: a case for revising the Atlanta classification to include “moderately severe acute pancreatitis”. Am J Gastroenterol. 2009;104:710–5.

    PubMed  Google Scholar 

  108. Lankisch PG, Schirren CA, Kunze E. Undetected fatal acute pancreatitis: why is the disease so frequently overlooked? Am J Gastroenterol. 1991;86:322–6.

    CAS  PubMed  Google Scholar 

  109. Forsmark CE, Vege SS, Wilcox CM. Acute pancreatitis. N Engl J Med. 2016;375:1972–81.

    Article  CAS  PubMed  Google Scholar 

  110. Lankisch PG, Apte M, Banks PA. Acute pancreatitis. Lancet. 2015;386:85–96.

    Article  PubMed  Google Scholar 

  111. Whitcomb DC. Genetic risk factors for pancreatic disorders. Gastroenterology. 2013;144:1292–302.

    Article  CAS  PubMed  Google Scholar 

  112. Sadr-Azodi O, Andren-Sandberg A, Orsini N, Wolk A. Cigarette smoking, smoking cessation and acute pancreatitis: a prospective population-based study. Gut. 2012;61:262–7.

    Article  CAS  PubMed  Google Scholar 

  113. Smeets X, Knoester I, Grooteman KV, Singh VK, Banks PA, Papachristou GI, Duarte-Rojo A, Robles-Diaz G, Kievit W, MGH B, Verdonk RC, Van Santvoort HC, JPH D, Belias M, EJM VG, Dutch Pancreatitis Study G. The association between obesity and outcomes in acute pancreatitis: an individual patient data meta-analysis. Eur J Gastroenterol Hepatol. 2019;31:316–22.

    Article  PubMed  Google Scholar 

  114. Di Paolo M, Marradi I. Haemorrhagic complication of acute necrotizing pancreatitis presenting with sudden death. J Clin Forensic Med. 2006;13:271–3.

    Article  PubMed  Google Scholar 

  115. Pastor CM, Matthay MA, Frossard JL. Pancreatitis-associated acute lung injury: new insights. Chest. 2003;124:2341–51.

    Article  PubMed  Google Scholar 

  116. Browne GW, Pitchumoni CS. Pathophysiology of pulmonary complications of acute pancreatitis. World J Gastroenterol. 2006;12:7087–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  117. Zhao X, Andersson R, Wang X, Dib M, Wang X. Acute pancreatitis-associated lung injury: pathophysiological mechanisms and potential future therapies. Scand J Gastroenterol. 2002;37:1351–8.

    Article  CAS  PubMed  Google Scholar 

  118. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology 2013;13:e1–15.

    Google Scholar 

  119. Turner B. Acute pancreatitis: symptoms, diagnosis and management. Nurs Times. 2003;99:38–40.

    PubMed  Google Scholar 

  120. Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, Tsiotos GG, Vege SS. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62:102–11.

    Article  PubMed  Google Scholar 

  121. Karagoz A, Unluer EE, Oyar O, Topal FE, Topal F. The ability of emergency physicians to diagnose and score acute pancreatitis on computed tomography. Eur J Trauma Emerg Surg. 2017;43:287–92.

    Article  CAS  PubMed  Google Scholar 

  122. Bollen TL, Singh VK, Maurer R, Repas K, van Es HW, Banks PA, Mortele KJ. A comparative evaluation of radiologic and clinical scoring systems in the early prediction of severity in acute pancreatitis. Am J Gastroenterol. 2012;107:612–9.

    Article  PubMed  Google Scholar 

  123. Siregar GA, Siregar GP. Management of severe acute pancreatitis. Maced J Med Sci. 2019;7:3319–23. Open Access

    Google Scholar 

  124. Balthazar EJ, Ranson JH, Naidich DP, Megibow AJ, Caccavale R, Cooper MM. Acute pancreatitis: prognostic value of CT. Radiology. 1985;156:767–72.

    Google Scholar 

  125. King NK, Powell JJ, Redhead D, Siriwardena AK. A simplified method for computed tomographic estimation of prognosis in acute pancreatitis. Scand J Gastroenterol. 2003;38:433–6.

    Google Scholar 

  126. Crockett SD, Wani S, Gardner TB, Falck-Ytter Y, Barkun AN. American gastroenterological association institute guideline on initial management of acute pancreatitis. Gastroenterology. 2018;154:1096–101.

    Article  PubMed  Google Scholar 

  127. Zhao G, Zhang JG, Wu HS, Tao J, Qin Q, Deng SC, Liu Y, Liu L, Wang B, Tian K, Li X, Zhu S, Wang CY. Effects of different resuscitation fluid on severe acute pancreatitis. World J Gastroenterol. 2013;19:2044–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  128. Bhadade RR, de Souza RA, Harde MJ, Khot A. Clinical characteristics and outcomes of patients with acute lung injury and ARDS. J Postgrad Med. 2011;57:286–90.

    Article  CAS  PubMed  Google Scholar 

  129. Sun B, Zhang C, Lin T, Liu S, Wang Z, Zhang J, Liu C. Effect of continuous renal replacement therapy during percutaneous drainage in severe acute pancreatitis patients: a retrospective cohort study. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019;31:714–8.

    PubMed  Google Scholar 

  130. Faghih M, Fan C, Singh VK. New advances in the treatment of acute pancreatitis. Curr Treat Option Gastroenterol. 2019;17:146–60.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Qi, S. et al. (2021). Digestive System Disease and Sudden Death. In: Zhu, H. (eds) Sudden Death. Springer, Singapore. https://doi.org/10.1007/978-981-15-7002-5_23

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-7002-5_23

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-7001-8

  • Online ISBN: 978-981-15-7002-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics